Loading...
Loading...
NYXH| Name | Value |
|---|---|
| Revenues | 1,307.0K |
| Cost of Revenue | 465.0K |
| Gross Profit | 842.0K |
| Operating Expense | 9,892.0K |
| Operating I/L | -9,050.0K |
| Other Income/Expense | -3,456.0K |
| Interest Income | 1,153.0K |
| Pretax | -12,506.0K |
| Income Tax Expense | 790.0K |
| Net Income/Loss | -13,296.0K |
Nyxoah S.A. is a medical technology company specializing in solutions for sleep disordered breathing conditions. Its flagship product, the Genio system, is a CE-Marked hypoglossal neurostimulation therapy designed to treat moderate to severe obstructive sleep apnea. The company generates revenue through the development and commercialization of its innovative medical devices, providing patients with a patient-centric approach to addressing their sleep apnea needs.
